Knowledge Centre
Two hair approaches, two mechanisms.
They both show up in hair research, but minoxidil and GHK-Cu work in completely different ways. Here is an honest, mechanism-first comparison of the vasodilator and the copper peptide.

The key to comparing them is understanding that they target different parts of the same problem.
In short: minoxidil pushes more supply to the follicle, while GHK-Cu is studied for improving the follicle’s environment and structure.
Minoxidil has the longer track record as an established hair-loss treatment. GHK-Cu is the newer, research-stage option, valued for a gentler mechanism and its broader skin and tissue benefits.
Because they act on different pathways, GHK-Cu and minoxidil are often studied as complementary rather than competing. The logic is straightforward: minoxidil improves the blood supply while GHK-Cu supports the surrounding tissue and tempers inflammation.
Which should you research first?
For research, GHK-Cu is reconstituted with bacteriostatic water and refrigerated once mixed; topical formulations are also studied for scalp work. Our reconstitution guide covers the standard method, and GHK-Cu for wound healing covers the underlying mechanism in more depth.
Not exactly. They work differently, so in research they are usually framed as complementary rather than one replacing the other.
No — hair is just one area. GHK-Cu is studied across skin firmness, wound healing, and general tissue repair.
The copper ion gives a correctly mixed solution a blue tint. It is expected, not a sign of contamination.